Kuo-Hsuan Hsu - Concepedia

Author

Kuo-Hsuan Hsu

Taichung Veterans General Hospital ORCID

Also Known As

-mutant non-small-cell lung cancer (NSCLC) patients, Hsu Kuo-Hsuan, K.H. Hsu, Kuo-Hsuan Hsu

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Taichung Veterans General Hospital National Yang Ming Chiao Tung University National Chung Hsing University National Taiwan University National Taiwan University Hospital

About

Kuo-Hsuan Hsu is an author at Taichung Veterans General Hospital specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	934
2	Public Health	4	4	383
3	Health Sciences	3	3	108
4	Cell Biology	3	3	129
5	Engineering	1	1	117

Kuo-Hsuan Hsu

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan Chien‐Hua Tseng, Ben‐Jei Tsuang, Chun‐Ju Chiang, Journal of Thoracic Oncology Environmental Lung DiseasesRespiratory ToxicologyGlobal HealthEnvironmental HealthSmoking Related Lung Disease	2019	220
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study Gee‐Chen Chang, Chao‐Hua Chiu, Chong‐Jen Yu, The Lancet Respiratory Medicine Tobacco ControlFamily MedicineCancer EpidemiologyMedical ImagingCancer Screening	2023	137
Factors affecting water uptake of soybeans during soaking. Kuo-Hsuan Hsu, C.J. Kim, L.A. Wilson Europe PMC (PubMed Central) EngineeringWater ResourcesAgricultural Water ManagementAgricultural EconomicsCrop Water Relation	1983	117
Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan Kuo-Hsuan Hsu, Chao‐Chi Ho, Te‐Chun Hsia, PLoS ONE	2015	115
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients Kuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng‐Sen Tseng, Lung Cancer MedicineImmunologyPathologyPrimary ResistanceBronchial Neoplasm	2018	104
R331W Missense Mutation of Oncogene <i>YAP1</i> Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability Hsuan‐Yu Chen, Sung‐Liang Yu, Bing‐Ching Ho, Journal of Clinical Oncology	2015	93
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma Chien‐Hua Tseng, Chun‐Ju Chiang, Jeng‐Sen Tseng, Oncotarget	2017	84
Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury Ya‐Jane Lee, Yu-Yen Hu, Yi-Shan Lin, BMC Veterinary Research	2012	79
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Journal of Thoracic Oncology	2014	71
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Cancer Research and Treatment	2018	62

Page 1